Lofexidine Hydrochloride
6 NDCs across 3 manufacturers|4 Generic,2 Brand
Lofexidine Hydrochloride is used to treat substance withdrawal syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 16, 2018, and the first generic was approved Aug 20, 2024. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient.
Lofexidine Hydrochloride is available as 6 NDCs from 3 manufacturers (4 generic, 2 brand), with NADAC prices from $7.88 to $23.22 per EA — the most expensive product costs about 2.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
4G / 2B
Manufacturers
3
competing in market
Price Spread
$7.88 – $23.22
per EA
7d Activity
avg -9.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
USWM, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing LOFEXIDINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LUCEMYRA 0.18 MG TABLET | $23.2208 per EA | — |
LUCEMYRA 0.18 MG TABLET | $23.2208 per EA | — |
LOFEXIDINE 0.18 MG TABLET | $7.8793 per EA | -8.98% |
LOFEXIDINE 0.18 MG TABLET | $7.8793 per EA | -8.98% |
LOFEXIDINE 0.18 MG TABLET | $7.8793 per EA | -8.98% |
LOFEXIDINE 0.18 MG TABLET | $7.8793 per EA | -8.98% |
Frequently Asked Questions
What is Lofexidine Hydrochloride used to treat?
Lofexidine Hydrochloride is used to treat substance withdrawal syndrome, per the National Library of Medicine's MED-RT classification.
When did Lofexidine Hydrochloride become available as a generic?
FDA approved the first generic Lofexidine Hydrochloride (ANDA) on Aug 20, 2024. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Lofexidine Hydrochloride products are on the market?
The Lofexidine Hydrochloride drug market contains 6 NDCs from 3 manufacturers — 4 generic and 2 brand products.
What is the price range for Lofexidine Hydrochloride?
NADAC reference prices for Lofexidine Hydrochloride range from $7.8793 to $23.2208 per EA — the most expensive product costs about 2.9× the cheapest.
Is generic Lofexidine Hydrochloride cheaper than brand?
The average generic NADAC for Lofexidine Hydrochloride is $7.8793 per EA, versus $23.2208 for brand-labeled products — brand versions average about 2.9× the generic price.
Which manufacturers make Lofexidine Hydrochloride?
3 manufacturers list Lofexidine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are USWM, LLC (2), Prasco Laboratories (2), Novadoz Pharmaceuticals LLC (2).
How has the price of Lofexidine Hydrochloride changed recently?
Over the past 7 days, 0 Lofexidine Hydrochloride NDCs rose and 4 fell, with a market-wide average change of -9.0%.